Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

No Angina? No Benefit to PCI Pre-TAVR: ACTIVATION

Shelley Wood

November 26, 2020

News Conference News AHA 2020

High Burden of Post-CABG A-fib After Hospital Discharge: SEARCH-AF

Michael O'Riordan

November 16, 2020

News Daily News

Failure to Access Coronaries After TAVR Almost Exclusive to CoreValve Evolut

Michael O'Riordan

October 28, 2020

Presentation TCT 2020

TCT 464: Risk of Coronary Obstruction Due to Sinus Sequestration in Repeat Transcatheter Aortic Valve Replacement

Presenter: Tomoki Ochiai

October 14, 2020

News Daily News

Which TAVR Device Is Best? Review Tackles Optimal Selection

Michael O'Riordan

September 09, 2020

News Industry News

Cardiac Dimensions Announces Australian Therapeutic Goods Administration's Approval of the Carillon System for the Treatment of Functional Mitral Regurgitation

September 02, 2020

News Conference News ESC 2020

Rhythm Control Cuts First CV Events in Early Atrial Fibrillation: EAST-AFNET 4

Shelley Wood

August 29, 2020

News Daily News

Which Modality and When? New Guidance for Cardiac Imaging in COVID-19

Shelley Wood

July 24, 2020

News Industry News

Miracor Medical’s PiCSO® System receives CE Mark

June 23, 2020

News Industry News

New Data Confirms Cardiac Dimensions’ Carillon® System Shows Favorable Long-Term Survival Rate In Patients With Functional Mitral Regurgitation

February 25, 2020

News Daily News

Preemptive Stents Feasible for TAVR Patients at High Risk for Coronary Occlusion

Yael L. Maxwell

February 14, 2020

News Daily News

ACS After TAVR a Unique Condition With Poor Prognosis

Todd Neale

February 05, 2020

Presentation BIT 2020

Positive Intermittent Coronary Sinus Occlusion for Myocardial Remodelling

Presenter: Aazfar Zaman

February 02, 2020

Advertisement

No Angina? No Benefit to PCI Pre-TAVR: ACTIVATION

High Burden of Post-CABG A-fib After Hospital Discharge: SEARCH-AF

Failure to Access Coronaries After TAVR Almost Exclusive to CoreValve Evolut

TCT 464: Risk of Coronary Obstruction Due to Sinus Sequestration in Repeat Transcatheter Aortic Valve Replacement

Which TAVR Device Is Best? Review Tackles Optimal Selection

Cardiac Dimensions Announces Australian Therapeutic Goods Administration's Approval of the Carillon System for the Treatment of Functional Mitral Regurgitation

Rhythm Control Cuts First CV Events in Early Atrial Fibrillation: EAST-AFNET 4

Which Modality and When? New Guidance for Cardiac Imaging in COVID-19

Miracor Medical’s PiCSO® System receives CE Mark

New Data Confirms Cardiac Dimensions’ Carillon® System Shows Favorable Long-Term Survival Rate In Patients With Functional Mitral Regurgitation

Preemptive Stents Feasible for TAVR Patients at High Risk for Coronary Occlusion

ACS After TAVR a Unique Condition With Poor Prognosis

Positive Intermittent Coronary Sinus Occlusion for Myocardial Remodelling

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content